$PEPG RA bought 1/3 of offering at $5: investors.pepgen.com/node/9561/html
BioValues
@BioValues
Biotech investor. Tend to focus on contrarian names, so I'm probably buying what you are selling/hating on. All tweets are my opinions only.
391 Following 10K Followers 26K Posts
Latest posts 5
$pepg nice opportunity to grab in $3s post data and offering at $5
$lxeo Lexeo is now designing a pivotal study with NSVT as a primary surrogate endpoint to support potential accelerated approval.
$lxeo blowout data
$LXEO wow, pre-announcing data event on a Sunday (almost never see that). Data/CC tomorrow AM: ir.lexeotx.com/news-releases/…
ir.lexeotx.com Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business... Company to host webcast at 8:00 AM ET NEW YORK, Nov. 15, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage company focused on reshaping the path of genetic diseases...